Cargando…

Direct comparison of Xpert Xpress, FilmArray Respiratory Panel, Lumipulse antigen test, and RT-qPCR in 165 nasopharyngeal swabs

BACKGROUND: The nucleic acid amplification test (NAAT) and antigen test are approved diagnostic tests for COVID-19. In this study, we aimed to investigate the assay performance of two NAATs (Xpert Xpress SARS-CoV-2 and FilmArray Respiratory Panel) and a quantitative antigen test (Lumipulse). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirotsu, Yosuke, Maejima, Makoto, Shibusawa, Masahiro, Natori, Yume, Nagakubo, Yuki, Hosaka, Kazuhiro, Sueki, Hitomi, Amemiya, Kenji, Hayakawa, Miyoko, Mochizuki, Hitoshi, Tsutsui, Toshiharu, Kakizaki, Yumiko, Miyashita, Yoshihiro, Omata, Masao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894560/ https://www.ncbi.nlm.nih.gov/pubmed/35246055 http://dx.doi.org/10.1186/s12879-022-07185-w

Ejemplares similares

Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR
por: Hirotsu, Yosuke, et al.
Publicado: (2021)

Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection
por: Hirotsu, Yosuke, et al.
Publicado: (2021)

SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022
por: Hirotsu, Yosuke, et al.
Publicado: (2022)

Classification of Omicron BA.1, BA.1.1, and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data
por: Hirotsu, Yosuke, et al.
Publicado: (2022)

Pooling RT-qPCR testing for SARS-CoV-2 in 1000 individuals of healthy and infection-suspected patients
por: Hirotsu, Yosuke, et al.
Publicado: (2020)

Non-pharmaceutical interventions during the COVID-19 epidemic changed detection rates of other circulating respiratory pathogens in Japan
por: Nagakubo, Yuki, et al.
Publicado: (2022)

Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan
por: Hirotsu, Yosuke, et al.
Publicado: (2020)

Reply to ‘Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan’
por: Hirotsu, Yosuke, et al.
Publicado: (2020)

Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients
por: Hirotsu, Yosuke, et al.
Publicado: (2020)

Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19
por: Hirotsu, Yosuke, et al.
Publicado: (2021)

Impact of the FilmArray Rapid Multiplex PCR Assay on Clinical Outcomes of Patients with Bacteremia
por: Okamoto, Mai, et al.
Publicado: (2023)

The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors
por: Omata, Masao, et al.
Publicado: (2021)

Analysis of significantly mutated genes as a clinical tool for the diagnosis in a case of lung cancer
por: Miyashita, Yoshihiro, et al.
Publicado: (2017)

Rapid Evaluation of the Xpert(®) Xpress CoV-2 plus and Xpert(®) Xpress CoV-2/Flu/RSV plus Tests
por: Noble, Lara Dominique, et al.
Publicado: (2022)

Detection of tumor-derived DNA dispersed in the airway improves the diagnostic accuracy of bronchoscopy for lung cancer
por: Goto, Taichiro, et al.
Publicado: (2017)

Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR
por: Nagakubo, Yuki, et al.
Publicado: (2019)

Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test
por: Johnson, Grant, et al.
Publicado: (2021)

Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay
por: Graham, Maryza, et al.
Publicado: (2021)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
por: Loeffelholz, Michael J., et al.
Publicado: (2020)

Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer
por: Kunimasa, Kei, et al.
Publicado: (2020)

Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2
por: Hirotsu, Yosuke, et al.
Publicado: (2023)

Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test for bronchoalveolar lavage
por: Phan, Tung, et al.
Publicado: (2022)

The Diagnostic Accuracy of Xpert Xpress to SARS-CoV-2: A systematic review
por: Cao, Xun-Jie, et al.
Publicado: (2022)

Recommendations for sample pooling on the Cepheid GeneXpert(®) system using the Cepheid Xpert(®) Xpress SARS-CoV-2 assay
por: Becker, Michael G., et al.
Publicado: (2020)

Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next‐generation sequencing
por: Amemiya, Kenji, et al.
Publicado: (2022)

Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay
por: Goldenberger, Daniel, et al.
Publicado: (2020)

Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay
por: Balgahom, Rifky, et al.
Publicado: (2022)

European multicenter evaluation of Xpert® Xpress SARS‐CoV‐2/Flu/RSV test
por: Wolters, Femke, et al.
Publicado: (2021)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test
por: Mostafa, Heba H., et al.
Publicado: (2021)

Lung Cancer Surgery With Persistent COVID-19 Infection
por: Nakagomi, Takahiro, et al.
Publicado: (2022)

Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay
por: Isles, Nicole, et al.
Publicado: (2022)

Deciphering a Case of SARS-CoV-2 E Gene Dropout With the Xpert Xpress Assay
por: Park, Kuenyoul, et al.
Publicado: (2023)

Rapid decrease of circulating tumor DNA predicted the treatment effect of nivolumab in a lung cancer patient within only 5 days
por: Iijima, Yuki, et al.
Publicado: (2017)

Validation of the GeneXpert Xpress SARS-CoV-2 PCR assay using saliva as biological specimen
por: Vaz, Sara Nunes, et al.
Publicado: (2021)

False positive results seen at high CT values with the Xpert Xpress SARS-CoV-2 test
por: Tan, Shireen Y.L., et al.
Publicado: (2022)

Validation of the Cepheid Xpert® Xpress SARS-CoV-2 using upper and lower respiratory tract specimens
por: Rong, Kassie, et al.
Publicado: (2022)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant
por: Choi, Hosoon, et al.
Publicado: (2022)

Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer
por: Hirotsu, Yosuke, et al.
Publicado: (2020)

Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay
por: Ruzzenente, Orazio, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2c0oq0vhvl3es8i2fq8m7n4u4g